Literature DB >> 7682878

Effects of melatonin on pulmonary and coronary vessels are exerted through perivascular nerves.

L B Weekley1.   

Abstract

The effects of melatonin on porcine pulmonary and coronary vessels have been studied. Vessels were isolated from normal pigs, placed in a tissue bath, and precontracted with 30 mM KCl. The biophysical responses to cumulative doses of melatonin were then assessed. In the pulmonary artery, melatonin caused a dose-dependent relaxation which was blocked by vasoactive intestinal peptide antagonists or prior 6-hydroxydopamine treatment of the vessels. In the coronary artery, melatonin caused the reverse, a dose-dependent contraction which was blocked by the alpha antagonist prazosin or prior 6-hydroxydopamine treatment. These experiments indicate that melatonin has different mechanisms of action in the coronary and pulmonary circulation, although both seem to depend on the integrity of perivascular 6-hydroxydopamine sensitive nerves. Such differing mechanisms may provide insight into pathophysiological events in the lungs (such as nocturnal asthma) and heart (early morning coronary infarction).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682878     DOI: 10.1007/bf01819143

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  15 in total

Review 1.  Onset of acute myocardial infarction--circadian variation and triggers.

Authors:  M C Cohen; J E Muller
Journal:  Cardiovasc Res       Date:  1992-09       Impact factor: 10.787

2.  Diurnal variations in central venous pressure.

Authors:  B T Engel; M I Talan
Journal:  Acta Physiol Scand       Date:  1991-02

Review 3.  Neuropeptides in human airways: function and clinical implications.

Authors:  P J Barnes
Journal:  Am Rev Respir Dis       Date:  1987-12

4.  Diurnal changes in coronary blood flow in conscious dogs.

Authors:  M Fujita; D Franklin
Journal:  Circulation       Date:  1987-08       Impact factor: 29.690

5.  Melatonin-induced relaxation of rat aorta: interaction with adrenergic agonists.

Authors:  L B Weekley
Journal:  J Pineal Res       Date:  1991-08       Impact factor: 13.007

6.  Nocturnal asthma: mechanisms and treatment.

Authors:  P J Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-12

7.  Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity.

Authors:  J A Panza; S E Epstein; A A Quyyumi
Journal:  N Engl J Med       Date:  1991-10-03       Impact factor: 91.245

8.  Enhanced vascular reactivity to various vasoconstrictor agents following pinealectomy in the rat: role of melatonin.

Authors:  S C Cunnane; M S Manku; M Oka; D F Horrobin
Journal:  Can J Physiol Pharmacol       Date:  1980-03       Impact factor: 2.273

9.  Effects of melatonin on isolated pulmonary artery and vein: role of the vascular endothelium.

Authors:  L B Weekley
Journal:  Pulm Pharmacol       Date:  1993-06

Review 10.  Alpha-adrenergic mechanisms in myocardial ischemia.

Authors:  G Heusch
Journal:  Circulation       Date:  1990-01       Impact factor: 29.690

View more
  6 in total

1.  Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study.

Authors:  P Lusardi; E Piazza; R Fogari
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

2.  Melatonin differentially affects vascular blood flow in humans.

Authors:  Jonathan S Cook; Charity L Sauder; Chester A Ray
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-10       Impact factor: 4.733

3.  Influence of melatonin on bovine pulmonary vascular and bronchial airway smooth muscle tone.

Authors:  L B Weekley
Journal:  Clin Auton Res       Date:  1995-02       Impact factor: 4.435

4.  Dose-dependent dual effect of melatonin on ototoxicity induced by amikacin in adult rats.

Authors:  Tamer Erdem; Orhan Ozturan; Mustafa Iraz; Murat Cem Miman; Ercument Olmez
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-05-28       Impact factor: 2.503

5.  Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure.

Authors:  Luis Girotti; Manuel Lago; Oscar Ianovsky; Marcelo V Elizari; Andrés Dini; Santiago Pérez Lloret; Liliana E Albornoz; Daniel P Cardinali
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

Review 6.  Melatonin for the Management of Preeclampsia: A Review.

Authors:  Annie Langston-Cox; Sarah A Marshall; Daisy Lu; Kirsten R Palmer; Euan M Wallace
Journal:  Antioxidants (Basel)       Date:  2021-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.